Related Experiment Video
Updated: Jul 13, 2026

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
Published on: April 23, 2015
Spirodela (duckweed) as an alternative production system for pharmaceuticals: a case study, aprotinin
Sandrine Rival1, Jean-Pierre Wisniewski, Audrey Langlais
1LemnaGene SA, 71 Chemin du Moulin Carron, Dardilly, France.
Abstract:
Aprotinin is a small serine protease inhibitor used in human health. Spirodela were transformed, via Agrobacterium, with a synthetic gene encoding the mature aprotinin sequence and a signal peptide for secretion which was driven by the CaMV 35S promoter. A total of 25 transgenic Spirodela lines were generated and aprotinin production was confirmed by northern and western blot analyses. Expression levels of up to 3.7% of water soluble proteins were detected in the plant and 0.65 mg/l in the growth medium. In addition, immunoaffinity purification of the protein followed by amino acid sequencing confirmed the correct splicing of the aprotinin produced in Spirodela and secreted into the growth medium.
Related Concept Videos
Production of Pharmaceuticals
Production of Antibiotics
Upstream Processing

